INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GDF8 AND ACTIVIN A AND USES THEREOF"

GENEVA, Jan. 7 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/035706) for "BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GDF8 AND ACTIVIN A AND USES THEREOF" on Jun 27, 2025. With publication no. WO/2026/006740, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GLASS, David (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591)

Abstract: The present invention is related to bispecific antigen binding molecul...